Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychosurgery01:30

Psychosurgery

44
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
44
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

156
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
156
Analgesia and Pain Management01:25

Analgesia and Pain Management

496
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
496
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

124
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
124
Ethics in Research01:56

Ethics in Research

22.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.9K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

219
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
219

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AAPM Consensus Guidelines on Neuromodulation Technologies and Neurocomputer Interfaces for Pain Management and Functional Recovery.

Pain medicine (Malden, Mass.)·2026
Same author

The Current Scope of Pain Medicine Fellowships: A Cross-Sectional Survey Study of Trainees, Directors, and Employers on Shaping Future Leaders.

Journal of pain research·2026
Same author

Current State of Orthobiologics in Treatment of Knee Osteoarthritis-Future Directions.

International journal of molecular sciences·2026
Same author

Editorial: Case reports in anesthesiology 2025.

Frontiers in medicine·2026
Same author

Regenerative Medicine Approaches to Craniofacial and Corneal Neuropathic Pain.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Correction: Brain-Centered Interventions for Nociplastic Pain: From Symptom Management to Pain Resolution.

Current pain and headache reports·2026

Related Experiment Video

Updated: Jun 4, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.6K

Ethical Considerations Regarding Psychedelics for Clinical Pain Research.

Christopher L Robinson1, Matthew Slitzky2, Michael E Schatman3,4

  • 1Department of Anesthesiology, Perioperative & Pain Medicine, Harvard Medical School, Brigham & Women's Hospital, Boston, MA, USA.

Journal of Pain Research
|December 23, 2024
PubMed
Summary

Psychedelics show promise for treating chronic pain, offering new hope where other treatments fail. Ethical research, guided by principles like autonomy and beneficence, is crucial for patient safety and responsible scientific advancement.

Keywords:
chronic paindrug enforcement administrationethicspsychedelicsresearch

More Related Videos

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:02

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

329
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.2K

Related Experiment Videos

Last Updated: Jun 4, 2025

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.6K
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
09:02

Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management

Published on: March 28, 2025

329
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.2K

Area of Science:

  • Psychiatry and Pain Management
  • Neuroscience and Pharmacology

Background:

  • Psychedelics, historically used for medicinal purposes, are gaining traction in psychiatric research.
  • Despite Schedule I classification, emerging evidence suggests therapeutic potential, especially for treatment-resistant depression.
  • Chronic pain affects millions, with limited non-opioid options, prompting exploration of psychedelics as novel treatments.

Purpose of the Study:

  • To explore the potential of psychedelics as alternative treatment modalities for chronic pain.
  • To address the ethical considerations and regulatory challenges in psychedelic research for pain management.
  • To advocate for principal-based research ethics to guide responsible psychedelic studies.

Main Methods:

  • Review of current clinical research on psychedelics in psychiatry and pain management.
  • Analysis of ethical principles (autonomy, beneficence, justice, nonmaleficence) applied to psychedelic research.
  • Examination of regulatory landscapes (FDA, DEA) impacting psychedelic drug development.

Main Results:

  • Psychedelics demonstrate potential therapeutic benefits for conditions like refractory depression.
  • Ethical challenges include protecting vulnerable populations and navigating complex regulations.
  • Transparent collaboration among patients, researchers, and regulatory bodies is essential.

Conclusions:

  • Careful planning and adherence to ethical principles are vital for responsible psychedelic research in chronic pain.
  • Balancing therapeutic promise with ethical integrity is paramount for patient well-being.
  • Principal-based ethics can guide stakeholders in advancing psychedelic research safely and effectively.